3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
19
Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, Non-Hodgkin
14
Hodgkin Disease
13
Multiple Myeloma
12
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Carcinoma, Non-Small-Cell Lung
11
Breast Neoplasms
11
Leukemia, Lymphocytic, Chronic, B-Cell
9
Glioblastoma
9
Lymphoma, B-Cell, Marginal Zone
8
Burkitt Lymphoma
8
Brain Neoplasms
8
Sezary Syndrome
7
Neoplasms
7
Lymphoma, T-Cell, Cutaneous
7
Leukemia
7
Congenital Abnormalities
7
Unspecified Adult Solid Tumor, Protocol Specific
6
Recurrence
6
Neuroblastoma
6
Mycosis Fungoides
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Large-Cell, Anaplastic
6
Breast Neoplasms, Male
6
Sarcoma
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Interventions
Methods
5
Surveys and Questionnaires
3
Radiosurgery
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Early Intervention, Educational
3
Brachytherapy
3
Biopsy
3
aflibercept
2
Vaccines, Synthetic
2
Vaccines
2
Trastuzumab
2
Sentinel Lymph Node Biopsy
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Papillomavirus Vaccines
2
Palliative Care
2
Counseling
2
Cisplatin
2
tremelimumab
1
tipifarnib
1
pembrolizumab
1
oncogene protein E7, Human papillomavirus type 16
1
nanocis
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
durvalumab
1
alovudine
1
aldesleukin
1
Wound Closure Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Vulvar Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled